기준가
$8.99
운용 규모
$2.4M
보수율
-
배당수익률
0.00%
베타
0.00
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| -10.17% | +9.38% | +4.01% | -14.30% | - | - |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | ISRG | Intuitive Surgical Inc | 12.99% |
| 2 | RMD | ResMed Inc | 10.92% |
| 3 | VEEV | Veeva Systems Inc Class A | 7.64% |
| 4 | GEHC | GE HealthCare Technologies Inc Common Stock | 7.33% |
| 5 | MRNA | Moderna Inc | 6.60% |
| 6 | IQV | IQVIA Holdings Inc | 6.54% |
| 7 | PHG | Koninklijke Philips NV ADR | 6.23% |
| 8 | PODD | Insulet Corp | 5.88% |
| 9 | DXCM | DexCom Inc | 5.09% |
| 10 | ZBH | Zimmer Biomet Holdings Inc | 4.16% |
Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
설정일: 2024-01-11